Health-related Quality of Life in Patients with Myofascial Pain Syndrome

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

1. 1.
   Quality of life and clinical trials. Lancet 1995, 346:1–2.Google Scholar
2. 2.
   Gill TM, Feinstein AR: A critical appraisal of the quality of quality-of-life measurements. JAMA 1994, 272:619–626.CrossRefPubMedGoogle Scholar
3. 3.
   The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995, 41:1403–1409.Google Scholar
4. 4.
   Khanna D, Tsevat J: Health-related quality of life: an introduction. Am J Manag Care 2007, 13(Suppl 9):S218–S223.PubMedGoogle Scholar
5. 5.
   Guyatt GH, Feeny DH, Patrick DL: Measuring health-related quality of life. Ann Intern Med 1993, 118:622–629.PubMedGoogle Scholar
6. 6.
   Burckhardt CS, Anderson KL: The Quality of Life Scale (QOLS): reliability, validity, and utilization. Health Qual Life Outcomes 2003, 1:60.CrossRefPubMedGoogle Scholar
7. 7.
   Ware JE Jr, Sherbourne CD: The MOS 36-item short form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473–483.CrossRefPubMedGoogle Scholar
8. 8.
   McCallum J: The SF 36 in an Australian sample: validating a new, generic health status measure. Aust J Public Health 1995, 19:160–166.CrossRefPubMedGoogle Scholar
9. 9.
   McHorney CA, Ware JE Jr, Raczek AE: The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993, 31:247–263.CrossRefPubMedGoogle Scholar
10. 10.
    Bullinger M, Alonso J, Apolone G, et al.: Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol 1998, 51:913–923.CrossRefPubMedGoogle Scholar
11. 11.
    Perneger TV, Leplège A, Etter JF: Cross-cultural adaptation of a psychometric instrument: two methods compared. J Clin Epidemiol 1999, 52:1037–1046.CrossRefPubMedGoogle Scholar
12. 12.
    Wagner AK, Gandek B, Aaronson NK, et al.: Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998, 51:925–932.CrossRefPubMedGoogle Scholar
13. 13.
    Ware JE Jr, Kosinski M, Bayliss MS, et al.: Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 1995, 33:AS264–AS279.CrossRefPubMedGoogle Scholar
14. 14.
    McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD: The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994, 32:40–66.CrossRefPubMedGoogle Scholar
15. 15.
    Bruce B, Fries JF: The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol 2003, 30:167–178.PubMedGoogle Scholar
16. 16.
    Hunt SM, McEwen T: The development of a subjective health indicator. Sociol Health Illn 1980, 2:231–246.CrossRefPubMedGoogle Scholar
17. 17.
    Simons DG, Travell JG, Simons LS, et al.: Travell & Simons’ Myofascial Pain and Dysfunction: The Trigger Point Manual, vol 1, edn 2. Baltimore, MD: Lippincott Williams & Wilkins; 1999:132.Google Scholar
18. 18.
    Borg-Stein J, Simons DG: Focused review: myofascial pain. Arch Phys Med Rehabil 2002, 83(3 Suppl 1):S40–S47, S48–S49.Google Scholar
19. 19.
    Lavelle ED, Lavelle W, Smith HS: Myofascial trigger points. Med Clin North Am 2007, 91:229–239.CrossRefPubMedGoogle Scholar
20. 20.
    Han SC, Harrison P: Myofascial pain syndrome and trigger-point management. Reg Anesth 1997, 22:89–101.CrossRefPubMedGoogle Scholar
21. 21.
    Graff-Radford SB: Myofascial pain: diagnosis and management. Curr Pain Headache Rep 2004, 8:463–467.CrossRefPubMedGoogle Scholar
22. 22.
    Thumboo J, Strand V: Health-related quality of life in patients with systemic lupus erythematosus: an update. Ann Acad Med Singapore 2007, 36:115–122.PubMedGoogle Scholar
23. 23.
    Hoffman DL, Dukes EM: The health status burden of people with fibromyalgia: a review of studies that assessed health status with SF-36 or the SF-12. Int J Clin Pract 2008, 62:115–126.CrossRefPubMedGoogle Scholar
24. 24.
    Bal S, Çeliker R: Health-related quality of life in patients with myofascial syndrome: a controlled clinical study. J Musculoskel Pain 2009, 17:173–177.CrossRefGoogle Scholar
25. 25.
    Tüzün EH, Albayrak G, Eker L, et al.: A comparison study of quality of life in women with fibromyalgia and myofascial pain syndrome. Disabil Rehabil 2004, 26:198–202.CrossRefPubMedGoogle Scholar
26. 26.
    Eyigör S, Ozdedeli S, Durmaz B: The prevalance of generalized soft tissue rheumatic conditions in Turkish medical students. J Clin Rheumatol 2008, 14:65–68.CrossRefPubMedGoogle Scholar
27. 27.
    Sahin N, Karataş O, Ozkaya M, et al.: Demographic features, clinical findings and functional status in a group of subjects with cervical myofascial pain syndrome. Agri 2008, 20:14–19.PubMedGoogle Scholar
28. 28.
    Irnich D, Behrens N, Molzen H, et al.: Randomised trial of acupuncture compared with conventional massage and “sham” laser acupuncture for treatment of chronic neck pain. BMJ 2001, 322:1574–1578.CrossRefPubMedGoogle Scholar
29. 29.
    Fransen J, van Riel PL: Outcome measures in inflammatory rheumatic diseases. Arthritis Res Ther 2009, 11:244.CrossRefPubMedGoogle Scholar
30. 30.
    Kosinski M, Keller SD, Ware JE Jr, et al.: The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: relative validity of scales in relation to clinical measures of arthritis severity. Med Care 1999, 37(5 Suppl):MS23–MS39.CrossRefPubMedGoogle Scholar
31. 31.
    Kiltz U, van der Heijde D: Health-related quality of life in patients with rheumatoid arthritis and in patients with ankylosing spondylitis. Clin Exp Rheumatol 2009, 27(4 Suppl 55):S108–S111.PubMedGoogle Scholar
32. 32.
    Laas K, Roine R, Räsänen P, et al.: Health-related quality of life in patients with common rheumatic diseases referred to a university clinic. Rheumatol Int 2009, 29:267–273.CrossRefPubMedGoogle Scholar
33. 33.
    Salaffi F, Sarzi-Puttini P, Girolimetti R, et al.: Health-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey. Clin Exp Rheumatol 2009, 27:S67–S74.PubMedGoogle Scholar
34. 34.
    Elliott TE, Renier CM, Palcher JA: Chronic pain, depression, and quality of life: correlations and predictive value of SF-36. Pain Med 2003, 4:331–339.CrossRefPubMedGoogle Scholar
35. 35.
    •• Börsbo B, Peolsson M, Gerdle B: The complex interplay between pain intensity, depression, anxiety and catastrophising with respect to quality of life and disability. Disabil Rehabil 2009, 31:1605–1613. This study highlights the interaction between psychological factors, pain, and quality of life in patients with chronic pain.CrossRefPubMedGoogle Scholar
36. 36.
    • Birtane M, Uzunca K, Taştekin N, Tuna H: The evaluation of quality of life in fibromyalgia syndrome: a comparison with rheumatoid arthritis by using SF-36 Health Survey. Clin Rheumatol 2007, 26:679–684. This study emphasizes that musculoskeletal conditions such as fibromyalgia syndrome lead to deterioration in quality of life comparable to rheumatoid arthritis.CrossRefPubMedGoogle Scholar
37. 37.
    Tander B, Cengiz K, Alayli G, et al.: A comparative evaluation of heath related quality of life and depression in patients with fibromyalgia syndrome and rheumatoid arthritis. Rheumatol Int 2008, 28:859–865.CrossRefPubMedGoogle Scholar
38. 38.
    Ge HY, Nie H, Madeleine P, et al.: Contribution of the local and referred pain from active myofascial trigger points in fibromyalgia syndrome. Pain 2009, 147:233–240.CrossRefPubMedGoogle Scholar
39. 39.
    Lew HL, Lee EH, Castaneda A, et al.: Therapeutic use of botulinum toxin type A in treating neck and upper back pain of myofascial origin: a pilot study. Arch Phys Med Rehabil 2008, 89:75–80.CrossRefPubMedGoogle Scholar
40. 40.
    Yoon SH, Rah UW, Sheen SS, Cho KH: Comparison of 3 needle sizes for trigger point injection in myofascial pain syndrome of upper- and middle-trapezius muscle: a randomized controlled trial. Arch Phys Med Rehabil 2009, 90:1332–1339.CrossRefPubMedGoogle Scholar
41. 41.
    Kamanlı A, Kaya A, Ardicoglu O, et al.: Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome. Rheumatol Int 2005, 25:604–611.CrossRefPubMedGoogle Scholar
42. 42.
    Gur A, Sarac AJ, Cevik R, et al.: Efficacy of 904 nm gallium arsenide low level laser therapy in the management of chronic myofascial pain in the neck: a double-blind and randomize-controlled trial. Lasers Surg Med 2004, 35:229–235.CrossRefPubMedGoogle Scholar
43. 43.
    Affaitati G, Fabrizio A, Savini A, et al.: A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds. Clin Ther 2009, 31:705–720.CrossRefPubMedGoogle Scholar